news Archives

• 2020-06-25
  ISSCR 2020 VIRTUAL, Modeling Development and Disease: Neural
  "Basic and translation disease modeling with patient iPSC-derived neural cells"
• 2020-03-25
  "Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice"
• 2020-03-19
  "Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease"
• 2019-12-02
  "Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: Protocol for a phase 1 dose escalation study of bosutinib for amyotrophic lateral sclerosis patients"
• 2019-02-09
  Japan-UK Neuroscience Symposium 2019, Chiba, Japan
  "Development of therapeutics for amyotrophic lateral sclerosis from iPSC research" presented by Dr. Keiko Imamura
• 2019-02-07
  International Symposium on NEW FRONTIER in NEUROSCIENCE, Kanazawa, Japan
  “iPSCs for neurological disorders: A decade of progress, hurdles, and beyond”
• 2018-07-04
  The 18th World Congress of Basic and Clinical Pharmacology (WCP2018). Kyoto, Japan
  "Human pluripotent stem cells in neurological disease modeling and drug discovery"
• 2018-03-25
  2018.3.25-3.29
  Keystone Symposia "iPSCs:A Decade of Progress and Beyond(C7)", California, USA>
  "Human Pluripotent Stem Cells in Neurological Drug Discovery"
• 2017-11-22
  "iPSC-based compound screening and in vitro trials identify a synergistic anti-amyloid β combination for Alzheimer's disease"
• 2017-11-20
  "Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis- related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons."